v3.25.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Deferred Shares
Additional Paid-in Capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Beginning balance (in shares) at Dec. 31, 2023   49,725,649 5,793,501      
Beginning balance at Dec. 31, 2023 $ 368,843 $ 134 $ 1 $ 1,149,643 $ (744,674) $ (36,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (24,436)       (24,436)  
Other comprehensive income 897         897
Exercise of share options (in shares)   280,436        
Exercise of share options 5,213 $ 1   5,212    
Share-based compensation expense 9,017     9,017    
Ending balance (in shares) at Mar. 31, 2024   50,006,085 5,793,501      
Ending balance at Mar. 31, 2024 359,534 $ 135 $ 1 1,163,872 (769,110) (35,364)
Beginning balance (in shares) at Dec. 31, 2023   49,725,649 5,793,501      
Beginning balance at Dec. 31, 2023 368,843 $ 134 $ 1 1,149,643 (744,674) (36,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (36,052)          
Ending balance (in shares) at Jun. 30, 2024   50,017,606 5,793,501      
Ending balance at Jun. 30, 2024 359,137 $ 135 $ 1 1,174,147 (780,726) (34,420)
Beginning balance (in shares) at Mar. 31, 2024   50,006,085 5,793,501      
Beginning balance at Mar. 31, 2024 359,534 $ 135 $ 1 1,163,872 (769,110) (35,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (11,616)       (11,616)  
Other comprehensive income 944         944
Exercise of share options (in shares)   11,521        
Exercise of share options 297     297    
Share-based compensation expense 9,978     9,978    
Ending balance (in shares) at Jun. 30, 2024   50,017,606 5,793,501      
Ending balance at Jun. 30, 2024 $ 359,137 $ 135 $ 1 1,174,147 (780,726) (34,420)
Beginning balance (in shares) at Dec. 31, 2024 50,064,860 50,064,860 5,793,501      
Beginning balance at Dec. 31, 2024 $ 360,716 $ 135 $ 1 1,190,104 (795,761) (33,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 5,023       5,023  
Other comprehensive income 673         673
Exercise of share options (in shares)   119,749        
Exercise of share options 2,551     2,551    
Share-based compensation expense 9,516     9,516    
Ending balance (in shares) at Mar. 31, 2025   50,184,609 5,793,501      
Ending balance at Mar. 31, 2025 $ 378,479 $ 135 $ 1 1,202,171 (790,738) (33,090)
Beginning balance (in shares) at Dec. 31, 2024 50,064,860 50,064,860 5,793,501      
Beginning balance at Dec. 31, 2024 $ 360,716 $ 135 $ 1 1,190,104 (795,761) (33,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (5,277)          
Exercise of share options (in shares) 307,208          
Ending balance (in shares) at Jun. 30, 2025 50,372,068 50,372,068 5,793,501      
Ending balance at Jun. 30, 2025 $ 388,481 $ 135 $ 1 1,215,997 (801,038) (26,614)
Beginning balance (in shares) at Mar. 31, 2025   50,184,609 5,793,501      
Beginning balance at Mar. 31, 2025 378,479 $ 135 $ 1 1,202,171 (790,738) (33,090)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,300)       (10,300)  
Other comprehensive income 6,476         6,476
Exercise of share options (in shares)   187,459        
Exercise of share options 3,670     3,670    
Share-based compensation expense $ 10,156     10,156    
Ending balance (in shares) at Jun. 30, 2025 50,372,068 50,372,068 5,793,501      
Ending balance at Jun. 30, 2025 $ 388,481 $ 135 $ 1 $ 1,215,997 $ (801,038) $ (26,614)